Image in article

Musk: Brain-Computer Interface Will Transform Treatment of Brain Disorders, Target Cost $5,000

At the 2024 Neurosurgery Physicians Conference, Elon Musk announced that Neuralink's brain-computer interface technology is expected to help address most brain disorders, with a future goal of reducing the device cost to $5,000. By capturing neural signals, this technology aims to treat conditions such as depression and Parkinson's disease, making brain disorder treatment more accessible and ushering in a new era of efficient and affordable healthcare.

Words 271Read Time 1 min
2024-10-29
2026-3-19

Neuralink's Breakthrough Goal: Brain-Computer Interface Poised to Address Brain Diseases, Cost Dropping to $5,000

At the recently held 2024 Congress of Neurological Surgeons (CNS 2024), Neuralink founder Elon Musk proposed that brain-computer interface technology could fundamentally transform how brain diseases are treated. He stated that the Neuralink device has the potential to address the vast majority of brain conditions and plans to reduce costs to approximately $5,000, similar to the price of laser vision correction surgery.

The Potential of Brain-Computer Interfaces: From Neural Repair to Disease Treatment

Musk believes the Neuralink device will be able to interact directly with the brain, thereby repairing neural functions or alleviating symptoms of various conditions. Through the implanted device, neural signals can be precisely captured and interpreted, with future applications potentially including treatment for depression, Parkinson's disease, spinal cord injuries, and numerous other conditions. Particularly when facing complex brain issues, this device can complement existing medical technologies, providing patients with more comprehensive treatment options.

The Challenge and Vision of Cost Reduction

Musk has proposed that Neuralink's future cost target is to drop to $5,000, making brain-computer interface treatment more accessible. The pricing comparable to laser vision correction surgery aims to make this technology affordable for more patients, enabling large-scale adoption. While still in the research and testing phase, Neuralink's goals are clear and the prospects promising, with substantial breakthroughs expected within the coming years.

Summary

Neuralink's brain-computer interface technology not only holds tremendous potential for treating brain diseases but also makes its application more accessible through cost reduction. If this vision is realized, it could fundamentally transform the field of neuromedicine, ushering brain disease treatment into an entirely new era.

Related Information: Neuralink